Specialities

Specialities

Anemia
COVID-19
Leukemia
Myeloproliferative Disorders
Hematologic Malignancies
Lymphoma
Myelodysplastic Syndrome
Pediatric Hematology
Rare Diseases
Thrombocytopenia
White Blood Cell Disorders
Genetic Blood Disorders
Amyloidosis
Autoimmune Blood Disorders
Blood and Bone Marrow Transplantation
Bloodstream Infections
Hemostatic Disorders
Maternal-fetal Medicine
Myeloma
Platelet Disorders
Policy
Transfusion Medicine
Search

Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Drug development in acute myeloid leukaemia picks up pace

touchHAEMATOLOGY

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Free CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchHEMATOLOGY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Advancing outcomes in CP–CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management

Dr Jorge Cortes, Dr Elias Jabbour, Dr Vivian Oehler

The panel reviews treatment decision-making and monitoring for patients with chronic-phase chronic myeloid leukaemia on tyrosine kinase inhibitors.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Evolving paradigms in PNH management: Interpreting the latest data

Prof. Bruno Fattizzo, Dr Austin Kulasekararaj, Dr Srikanth Nagalla

Three experts discuss the latest advances in PNH pathophysiology, diagnosis and therapeutics.

Translations available:
60 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025

Dr Rakesh Popat, Dr Paula Rodríguez-Otero, Dr Roberto Mina

Three experts discuss latest data from IMS and ASH 2025 on BCMA-directed agents for multiple myeloma.

Translations available:
36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

Dr Laura Fox, Prof. Claire Harrison

Watch expert haematologists discuss managing cytopenias in patients with myelofibrosis.

Translations available:
37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics

Prof. Lucia de Franceschi

A leading sickle cell disease expert discusses burden, treatment and strategies for effective lifespan care.

Translations available:
36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

Prof. Jesús San Miguel, Prof. Pieter Sonneveld, Dr Francesca Gay

Three experts discuss the practicalities of BCMA-directed therapies in RRMM.

Translations available:
Series of 3
CE/CME accredited
touchCurriculum

Management of RRMM with BCMA-directed therapies

Discover the rationale, selection criteria, practical considerations and emerging strategies for optimzing patient outcomes with BCMA-directed therapes in RRMM.
68 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025

Prof. Philippe Moreau, Prof. Hermann Einsele, Dr Paola Neri

Three experts discuss latest data from COMy, ASCO and EHA 2025 on BCMA-targeting agents in multiple myeloma.

Translations available:
34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia

Prof. Haifa Kathrin Al-Ali, Prof. Alessandro Vannucchi, Prof. Jean-Jacques Kiladjian

Three experts discuss the burden of myelofibrosis and anaemia/thrombocytopenia and targeted treatment options.

Translations available:
15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Looking to the future in the treatment of steroid-refractory chronic GvHD

Dr Corey Cutler

Expert insights on new and emerging approaches to optimize the management of steroid-refractory cGvHD.

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024

Prof. Katja Weisel, Dr Nisha Joseph, Prof. Roman Hájek

Three experts discuss data presented at ASH 2024 on BCMA-targeting agents in multiple myeloma.

Translations available:
40 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

What's new in primary ITP? Key updates from ASH 2024

Dr Hanny Al-Samkari, Dr Drew Provan, Dr Barbara Skopec

Three expert haematologists discuss current and emerging treatments for ITP as well as the disease burden.

Translations available:
90 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchSYMPOSIUM

Collaboration in chronic ITP: Improving quality of life and patient outcomes

Prof. Cindy Neunert, Prof. David Kuter, Dr María Eva Mingot Castellano

Leading experts discuss the impact of ITP on patients and review current and emerging treatment strategies.

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

Prof. María-Victoria Mateos, Dr Rakesh Popat, Prof. Evangelos Terpos

Three experts discuss data presented at COMy and EHA 2024 on BCMA-targeting agents in multiple myeloma.

Translations available:
51 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?

Dr Vickie McDonald, Prof. Waleed Ghanima, Prof. James B Bussel

Three experts discuss data presented at EHA and ISTH 2024 on the impact and management of ITP.

Translations available:
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma: From optimal sequencing to shared decision-making

Dr Matthew Lunning, Professor Charalambos Andreadis, Dr Tara Graff

Haematology experts discuss the latest on novel therapies and treatment selection and sequencing in R/R FL

Translations available:
52 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management

Prof. Dr Vito Sabato, Dr Sigurd Broesby-Olsen, Prof. Prithviraj Bose

Multidisciplinary experts discuss the diagnosis and management of patients with systemic mastocytosis.

Translations available:
48 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team

Prof. Michael Jordan, Dr Kate Kernan, Dr Eric Gars, Prof. Rob MacLaren

Multidisciplinary experts discuss the diagnosis and management of haemophagocytic lymphohistiocytosis (HLH)

Translations available:
Load More...

Society & Congress Partners

touchHEMATOLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Latest Medical Education - straight to your inbox

Close Popup